NICOX SA
Last · Paris€0.295+0.005 (+1.72%)live · yahoo · 4h ago
Vol 51.3K ≈ 15.1K
MA10MA20MA50
Market cap€28.7M97.2M sh
P/E · TTM-9.8fwd -1.2 · eps -0.03 · loss
Beta0.53vs S&P 500
Div yield0.00%annual · TTM
52w range
€0.281€0.569
Volume51.3Ksession
Issuer
Legal nameNICOX SA
HQEurope (EU)
ListingEU COX
ISINFR0013018124
SectorHealthcare
IndustryPharmaceuticals
CurrencyEUR
Entity registrylei:969500EZGEO9W4JXR353
Websitewww.nicox.com
Employees10
AddressNicox SA Emerald Square 06410, Biot +33 4 97 24 53 00
| Revenue | €7.2M |
|---|---|
| Operating income | €-46.0M |
| Net income | €-43.8M |
| Free cash flow | €-18.5M |
| Operating margin | -636.1% |
| Net margin | -605.0% |
| Return on equity | -57.9% |
| Period | 2021 |
Loading chart…
OpenFilings analyst
Our analyst
ANNUAL · 2022-04-29
From latest ANNUAL · 2022-04-29
- Operating Cf Burn
- Net Margin Sharply Negative
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -605.0%
Press & signals
- GlobeNewswire
Data on Nicox's NCX 470 to be presented at AAOpt Annual Meeting 2026
- GlobeNewswire
Nicox Announces NCX 470 NDA in China Accepted for Review
- GlobeNewswire
Nicox Announces Extension of Cash Runway
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags
Showing 5 of 365 filings